Bruker Corp. is moving ahead with plans to create a new energy services company separate from its primary medical device business, tapping a trio of new directors for its Bruker Energy & Supercon subsidiary.
Joining the BEST board of directors are Brenda Furlong, Thomas Hartkopf and Christopher van Ingen. Furlong, a former banking and insurance executive with the Hartford Financial Services Group and Bank of America, also is a member of the Bruker Corp. board. Hartkopf has been chair of the Renewable Energy department at the Darmstadt University of Technology in Germany since 1996; van Ingen led the Life Sciences and Chemical Analysis Group at Agilent Technologies until 2007.
Other BEST directors include Bruker Corp. CEO Frank Laukien, Joerg Laukien and Tony Keller.
Bruker officials earlier this summer reorganized several of its non-medical businesses into a stand-alone unit, with plans to eventually spin BEST off into a stand-alone company, most likely through an initial public offering.
Through the first six months of 2009, the unit posted a $3.1 million net loss on $21.8 million in revenues. a $600,000 improvement to the bottom line despite a 2.6 percent drop in revenues compared with the first six months of 2008.
Full company profit and revenues at Bruker Corp. were $21.3 million and $483 million, respectively, during the first six months of 2009. The company will announce third-quarter results in early November but has not yet set a date.